8 records, the earliest from 23 Jan 2025. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
8 shown, page 1 of 1.
| Date | Purpose | Notes |
|---|---|---|
| 27 Jul 2026 | Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2026 and other business matters |
| 14 May 2026 | Financial Results/Other business matters | To consider and approve Audited Consolidated and Standalone Financial Results Of The Company For The Quarter And financial year Ended March 31, 2026 And To Transact Other Business Matters |
| 20 Jan 2026 | Financial Results/Other business matters | Senores Pharmaceuticals Limited has informed the exchange that the meeting of the Board of Directors of the Company is scheduled on January 20, 2026 ,inter alia, to consider and approve Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and Nine Months ended December 31, 2025 and to transact other business matters |
| 7 Jan 2026 | Fund Raising/Other business matters | Senores Pharmaceuticals Ltd has informed the exchange that the meeting of the Board of Directors of the Company is scheduled on 07/01/2026, inter alia, to consider and approveproposals for raising funds by way of issue of convertible warrants on preferential basis to the promotors/promoter group including determination of issue price. |
| 6 Nov 2025 | Financial Results/Other business matters | To consider and approve the financial results for the quarter and half year ended September 30, 2025 and to transact other business matters |
| 23 Jul 2025 | Financial Results/Other business matters | Senores Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on July 23, 2025 to consider and approve the Un-audited Standalone and Consolidated financial results of the Company for the quarter ended June 30, 2025 and to transact other business matters. |
| 15 May 2025 | Financial Results/Other business matters | Senores Pharmaceuticals Limited has informed the Exchange that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve the Audited Standalone and Consolidated Financial Results of the Company, for the quarter and financial year ended March 31, 2025; and to transact any other business matters. |
| 23 Jan 2025 | Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
